Personalis, Inc. Revenue
Personalis, Inc. (PSNL) reported Revenue of $22.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-04
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $22.36M, a 29.96% increase year-over-year.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $15.47M, a 24.91% decline year-over-year.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $17.34M, a 3.24% increase year-over-year.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $14.49M, a 43.62% decline year-over-year.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $69.65M, a 17.69% decline from fiscal 2024.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $84.61M, a 15.15% increase from fiscal 2023.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $73.48M, a 12.97% increase from fiscal 2022.
- Personalis, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $65.05M, a 23.92% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.36M 10-Q · filed 2026-08-04 | $37.83M 10-Q · filed 2026-08-04 | $55.17M derived: sum of 3 quarters · filed 2026-08-04 | $69.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $15.47M 10-Q · filed 2026-05-07 | $32.82M derived: sum of 2 quarters · filed 2026-05-07 | $47.31M derived: sum of 3 quarters · filed 2026-05-07 | $64.52M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $17.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.84M derived: sum of 2 quarters · filed 2026-02-26 | $49.04M derived: sum of 3 quarters · filed 2026-08-04 | $69.65M 10-K · filed 2026-02-26 |
| 2025-09-30 | $14.49M 10-Q · filed 2025-11-04 | $31.70M derived: sum of 2 quarters · filed 2026-08-04 | $52.30M 10-Q · filed 2025-11-04 | $69.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $17.20M 10-Q · filed 2026-08-04 | $37.81M 10-Q · filed 2026-08-04 | $54.61M derived: sum of 3 quarters · filed 2026-08-04 | $80.32M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $20.61M 10-Q · filed 2026-05-07 | $37.41M derived: sum of 2 quarters · filed 2026-05-07 | $63.11M derived: sum of 3 quarters · filed 2026-05-07 | $85.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.51M derived: sum of 2 quarters · filed 2026-02-26 | $65.09M derived: sum of 3 quarters · filed 2026-02-26 | $84.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $25.71M 10-Q · filed 2025-11-04 | $48.29M derived: sum of 2 quarters · filed 2025-11-04 | $67.81M 10-Q · filed 2025-11-04 | $87.49M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $22.58M 10-Q · filed 2025-08-05 | $42.10M 10-Q · filed 2025-08-05 | $61.78M derived: sum of 3 quarters · filed 2025-08-05 | $80.03M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $19.52M 10-Q · filed 2025-05-06 | $39.20M derived: sum of 2 quarters · filed 2025-05-06 | $57.45M derived: sum of 3 quarters · filed 2025-05-06 | $74.15M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $19.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $37.92M derived: sum of 2 quarters · filed 2025-02-27 | $54.62M derived: sum of 3 quarters · filed 2025-02-27 | $73.48M 10-K · filed 2025-02-27 |
| 2023-09-30 | $18.25M 10-Q · filed 2024-11-06 | $34.95M derived: sum of 2 quarters · filed 2024-11-06 | $53.81M 10-Q · filed 2024-11-06 | $70.53M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $16.70M 10-Q · filed 2024-08-07 | $35.56M 10-Q · filed 2024-08-07 | $52.28M derived: sum of 3 quarters · filed 2024-08-07 | $67.14M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $18.86M 10-Q · filed 2024-05-08 | $35.58M derived: sum of 2 quarters · filed 2024-05-08 | $50.44M derived: sum of 3 quarters · filed 2024-05-08 | $68.68M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $16.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $31.58M derived: sum of 2 quarters · filed 2024-02-28 | $49.82M derived: sum of 3 quarters · filed 2024-02-28 | $65.05M 10-K · filed 2024-02-28 |
| 2022-09-30 | $14.86M 10-Q · filed 2023-11-07 | $33.10M derived: sum of 2 quarters · filed 2023-11-07 | $48.33M 10-Q · filed 2023-11-07 | $69.01M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $18.24M 10-Q · filed 2023-08-08 | $33.47M 10-Q · filed 2023-08-08 | $54.15M derived: sum of 3 quarters · filed 2024-02-28 | $76.41M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $15.23M 10-Q · filed 2023-05-03 | $35.91M derived: sum of 2 quarters · filed 2024-02-28 | $58.17M derived: sum of 3 quarters · filed 2024-02-28 | $79.84M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $20.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $42.94M derived: sum of 2 quarters · filed 2024-02-28 | $64.61M derived: sum of 3 quarters · filed 2024-02-28 | $85.49M 10-K · filed 2024-02-28 |
| 2021-09-30 | $22.26M 10-Q · filed 2022-11-02 | $43.93M derived: sum of 2 quarters · filed 2022-11-02 | $64.81M 10-Q · filed 2022-11-02 | $84.99M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $21.67M 10-Q · filed 2022-08-03 | $42.55M 10-Q · filed 2022-08-03 | $62.73M derived: sum of 3 quarters · filed 2023-02-23 | $82.54M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $20.88M 10-Q · filed 2022-05-04 | $41.06M derived: sum of 2 quarters · filed 2023-02-23 | $60.87M derived: sum of 3 quarters · filed 2023-02-23 | $80.37M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $20.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $39.99M derived: sum of 2 quarters · filed 2023-02-23 | $59.49M derived: sum of 3 quarters · filed 2023-02-23 | $78.65M 10-K · filed 2023-02-23 |
| 2020-09-30 | $19.82M 10-Q · filed 2021-11-04 | $39.31M derived: sum of 2 quarters · filed 2021-11-04 | $58.47M 10-Q · filed 2021-11-04 | $76.63M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $19.50M 10-Q · filed 2021-08-04 | $38.66M 10-Q · filed 2021-08-04 | $56.81M derived: sum of 3 quarters · filed 2021-08-04 | $73.96M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $19.16M 10-Q · filed 2021-05-05 | $37.31M derived: sum of 2 quarters · filed 2021-05-05 | $54.47M derived: sum of 3 quarters · filed 2021-05-05 | $70.29M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $18.15M 10-K · filed 2020-03-25 | $35.31M derived: sum of 2 quarters · filed 2020-11-05 | $51.13M derived: sum of 3 quarters · filed 2020-11-05 | $65.21M 10-K · filed 2022-02-24 |
| 2019-09-30 | $17.15M 10-Q · filed 2020-11-05 | $32.98M derived: sum of 2 quarters · filed 2020-11-05 | $47.05M 10-Q · filed 2020-11-05 | $60.21M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $15.82M 10-Q · filed 2020-08-06 | $29.90M 10-Q · filed 2020-08-06 | $43.06M derived: sum of 3 quarters · filed 2020-08-06 | $54.71M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $14.07M 10-Q · filed 2020-05-07 | $27.23M derived: sum of 2 quarters · filed 2020-05-07 | $38.89M derived: sum of 3 quarters · filed 2020-05-07 | $47.69M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $13.16M 10-K · filed 2020-03-25 | $24.81M derived: sum of 2 quarters · filed 2020-03-25 | $33.61M derived: sum of 3 quarters · filed 2020-03-25 | $37.77M 10-K · filed 2021-02-25 |
| 2018-09-30 | $11.65M 10-K · filed 2020-03-25 | $20.45M derived: sum of 2 quarters · filed 2020-03-25 | $24.62M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $8.80M 10-K · filed 2020-03-25 | $12.96M 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $4.16M 10-K · filed 2020-03-25 | |||
| 2017-12-31 | $9.39M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |